(CIDRAP News) Two vaccine companies have received contracts estimated at about $200 million to produce a modified smallpox vaccine for the US government.
Acambis, based in Cambridge, UK, and Cambridge, Mass., and Denmark's Bavarian Nordic both won contracts on Sep 30 to continue research on a smallpox vaccine made with a modified version of the currently used live vaccinia (Dryvax) vaccine, news services reported.